An international consortium of researchers, led by EMBL Australia group leader Professor David Lynn, has painstakingly mapped an intracellular network that could open the door to discovering new targeted treatments for colorectal cancer. 

An EMBL Australia group leader has co-developed a powerful 3D-printed microscope, making it widely available so researchers can easily harness this powerful technology.

News this quarter:

• Six group leaders awarded NHMRC Ideas Grants  
• ARC Grant for novel study of brain function using plant receptors
• Group leader position at UNSW
• High hopes for futuristic tissue-healing method
• Science by the sea: EMBL Partnership Conference
• Max Cryle to lead Victorian node of new $35 million ARC research centre
• EAPS 2019: Student-run symposium continues to shine
• Profile: Dr Senthil Arumugam, EMBL Australia group leader

And more:

• Job opportunities
• Upcoming events
• Recent publications
• Student opportunities

Six EMBL Australia group leaders have been awarded more than $4.3 million in funding for their innovative research through the National Health and Medical Research Council (NHMRC)’s Ideas Grant scheme.

EMBL Australia group leader Dr Harald Janovjak has been awarded a $600,000 ARC Discovery Projects Grant for research that will expand our ability to manipulate nerve cell function with high specificity and without side effects.

An international team of scientists, led by EMBL Australia group leader Associate Professor Mikaël Martino, has cleared the way for the use of growth factors to promote tissue repair by improving the delivery system of the molecules, busting cancer side effects and potentially slashing costs.

Researchers from around the world – including a group from our Partner Laboratory Network – gathered by the sea in sunny Barcelona for the 3rd EMBL Partnership Conference, which aimed to foster collaboration within the wider EMBL network.

EMBL Australia group leader Associate Professor Max Cryle will lead the Victorian node of the new ARC Centre of Excellence for innovations in Peptide and Protein Science.

News this quarter:

• Study shines light on mysteries of ‘unusual’ antibiotic   
• Grant success for Group Leader Mikaël Martino
• 6th EMBL Australia PhD Course 
• Funding Science, Funding Futures:  European Approaches
• EMBL in Australia 2019 
• Short-term travel grants - apply now!
• 2019 EMBL Australia Postgraduate Symposium (EAPS)

And more:

• Job opportunities
• Upcoming events
• Recent publications
• Student opportunities

Max Cryle and his team have revealed a novel mechanism in glycopeptide antibiotics (GPA) biosynthesis that may help in the development of new antibiotics.  Their findings were published in Chemical Science.